Samrat Pharmachem Ltd. - SAMRATPH, 530125 corporate action history

Samrat Pharmachem Ltd.

BSE: 530125

Value Stock, Under Radar

Download real time

317.50 -5.10 (-1.58%)

New 52W Low in past week

16,777 BSE Volume

High volume today

BSE 27 Mar, 2025 3:31 PM (IST)

98.1

Market Cap

Below industry Median

0.7

Beta 1Year

Very Low volatility

Samrat Pharmachem Ltd. Bonus history

Samrat Pharmachem Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Samrat Pharmachem Ltd. Split history

Samrat Pharmachem Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. has declared 3 dividends since Sept. 22, 2022.

In the past 12 months, Samrat Pharmachem Ltd. has declared an equity dividend amounting to ₹1.00 per share.

At the current share price of ₹317.5000, Samrat Pharmachem Ltd.'s dividend yield is 0.31%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep 2024	1.00	FINAL	19 Sep 2024	Equity Share
18 Sep 2023	1.00	FINAL	18 Sep 2023	Equity Share
22 Sep 2022	1.00	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Samrat Pharmachem Ltd.

The next board meeting for Samrat Pharmachem Ltd. is on 30 May 2025 for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
30 May 2025	Audited Results & Final Dividend	-
14 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
30 May 2024	Audited Results & Final Dividend	-
14 Feb 2024	Quarterly Results	-
08 Nov 2023	Quarterly Results	-
14 Aug 2023	Quarterly Results	-
30 May 2023	Audited Results & Dividend	-
16 Mar 2023	Others	Inter alia, to consider and approve re-appointment of 3 Executive Directors of the company.

See all Board Meetings for Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. Rights history

Samrat Pharmachem Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Samrat Pharmachem Ltd.

Is Samrat Pharmachem Ltd. worth buying?

44 Votes:

Buy 68.18%

Sell 13.64%

Hold 18.18%